title: Catheter-directed tissue plasminogen activator infusion and concurrent systemic anticoagulation with heparin to treat portal vein thrombosis post orthoptic liver transplantation.
authors.forename: Parneet
authors.initials: P
authors.lastname: Gill
authors.forename: Gabriel C
authors.initials: GC
authors.lastname: Oniscu
authors.forename: David A
authors.initials: DA
authors.lastname: Mayer
authors.forename: Darius F
authors.initials: DF
authors.lastname: Mirza
authors.forename: Simon
authors.initials: S
authors.lastname: Olliff
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D002404:Catheterization; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D011169:Portal Vein / Q000000981:diagnostic imaging; D011859:Radiography; D013156:Splenectomy / Q000009:adverse effects; D015912:Thrombolytic Therapy / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D020246:Venous Thrombosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D010959:Tissue Plasminogen Activator